Published in Science on August 27, 1999
Human RAS superfamily proteins and related GTPases. Sci STKE (2004) 3.80
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci U S A (2007) 2.48
Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol Cell Biol (2000) 1.95
Class II transactivator: mastering the art of major histocompatibility complex expression. Mol Cell Biol (2000) 1.66
Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol Cell Biol (2000) 1.62
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol Cell Biol (2000) 1.39
Plant intracellular innate immune receptor Resistance to Pseudomonas syringae pv. maculicola 1 (RPM1) is activated at, and functions on, the plasma membrane. Proc Natl Acad Sci U S A (2011) 1.31
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. J Biol Chem (2012) 1.26
A new eye on NLR proteins: focused on clarity or diffused by complexity? Curr Opin Immunol (2012) 1.24
Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Mol Cell Biol (2003) 1.16
Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains. Mol Cell Biol (2001) 1.16
The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem Biophys Res Commun (2012) 1.07
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. EMBO J (2002) 1.05
Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins. J Biol Chem (2012) 1.01
Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines. Mol Cell Biol (2001) 1.01
TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. PLoS One (2012) 0.98
CIITA and Its Dual Roles in MHC Gene Transcription. Front Immunol (2013) 0.95
Self-association of CIITA and its transactivation potential. Mol Cell Biol (2001) 0.92
Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator. J Biol Chem (2008) 0.89
The PYRIN domain in signal transduction. Curr Protein Pept Sci (2007) 0.85
Perspectives: immunology. Regulating the regulator. Science (1999) 0.83
NLRC5, at the Heart of Antigen Presentation. Front Immunol (2013) 0.83
Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y. Proc Natl Acad Sci U S A (2006) 0.82
Assessing ATP binding and hydrolysis by NLR proteins. Methods Mol Biol (2013) 0.78
Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag. PLoS One (2010) 0.77
ATP binding by NLRP7 is required for inflammasome activation in response to bacterial lipopeptides. Mol Immunol (2015) 0.76
Class II transactivator (CIITA) mediates transcriptional repression of pdk4 gene by interacting with hypermethylated in cancer 1 (HIC1). J Biomed Res (2015) 0.75
Molecular characterization of chicken class II transactivator gene. Immunogenetics (2014) 0.75
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene (2007) 11.85
Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science (1997) 6.50
Increasing complexity of Ras signaling. Oncogene (1998) 5.71
Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A (1982) 5.39
Biological and biochemical properties of human rasH genes mutated at codon 61. Cell (1986) 5.05
p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci U S A (1989) 4.80
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol (1995) 4.78
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature (1997) 4.66
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science (1988) 4.58
GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J Cell Biol (1992) 4.34
Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol (2000) 3.86
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50
Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (1997) 3.32
Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. J Cell Biol (1991) 3.22
Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell (1989) 3.12
Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol (1997) 3.09
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell (1993) 2.92
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell (2001) 2.89
A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (1990) 2.83
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol (1996) 2.69
The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J Biol Chem (1996) 2.60
Increasing complexity of the Ras signaling pathway. J Biol Chem (1998) 2.56
Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol (1995) 2.56
Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem (1997) 2.55
The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol (2000) 2.38
Critical role of Rho in cell transformation by oncogenic Ras. Oncogene (1995) 2.37
Dbl family proteins. Biochim Biophys Acta (1997) 2.36
How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J (2000) 2.33
Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell (1983) 2.27
Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27
The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J (1997) 2.19
Biological assays for Ras transformation. Methods Enzymol (1995) 2.16
Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16
The Ras signal transduction pathway. Cancer Metastasis Rev (1994) 2.13
Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci U S A (1992) 2.10
Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal. Science (1989) 2.04
Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene. Proc Natl Acad Sci U S A (1987) 2.00
Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene (1998) 1.99
Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Proc Natl Acad Sci U S A (1991) 1.99
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J Biol Chem (1997) 1.98
Lck regulates Vav activation of members of the Rho family of GTPases. Mol Cell Biol (1997) 1.96
PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Biol (1994) 1.95
Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem (2000) 1.93
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci U S A (1990) 1.84
Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem (1999) 1.82
Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21. Cell (1984) 1.76
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat (1995) 1.75
Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem (1995) 1.75
rasH mutants deficient in GTP binding. Mol Cell Biol (1986) 1.73
Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc Natl Acad Sci U S A (1994) 1.67
Class II transactivator: mastering the art of major histocompatibility complex expression. Mol Cell Biol (2000) 1.66
The six amino-terminal amino acids of p60src are sufficient to cause myristylation of p21v-ras. Mol Cell Biol (1988) 1.65
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol (1998) 1.63
Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol Cell Biol (2000) 1.62
Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol (1994) 1.60
ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun. Mol Cell Biol (1989) 1.59
Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioessays (1995) 1.57
Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J (1993) 1.56
Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol (1998) 1.55
Protein prenylation: more than just glue? Curr Opin Cell Biol (1992) 1.54
Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells. J Biol Chem (1999) 1.53
CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J (1994) 1.53
The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein. Mol Cell Biol (1991) 1.52
Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity (1997) 1.51
Biological assays for cellular transformation. Methods Enzymol (1994) 1.51
Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol Cell Biol (1999) 1.50
Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected]. J Biol Chem (1996) 1.50
Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene (1994) 1.48
Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med (2001) 1.46
Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med (1995) 1.46
Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line. Proc Natl Acad Sci U S A (1988) 1.46
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci U S A (1996) 1.46
Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett (2001) 1.45
Identification of an interferon-gamma response region 5' of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines. J Immunol (1987) 1.45
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem (2001) 1.44
Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc Natl Acad Sci U S A (1994) 1.44
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils. J Immunol (1991) 1.43
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim Biophys Acta (1997) 1.42
R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene (1994) 1.42
Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. J Biol Chem (1996) 1.42
MEK inhibition enhances paclitaxel-induced tumor apoptosis. J Biol Chem (2000) 1.40
Molecular basis for Rac1 recognition by guanine nucleotide exchange factors. Nat Struct Biol (2001) 1.39
Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol Cell Biol (1992) 1.39
Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem (1996) 1.39
Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J Biol Chem (1994) 1.39
Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity (1994) 1.39
Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J Biol Chem (2001) 1.39
Dependence of Dbl and Dbs transformation on MEK and NF-kappaB activation. Mol Cell Biol (1999) 1.38
Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem (1999) 1.38
Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev (2009) 1.36
Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity (1996) 1.35
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc Natl Acad Sci U S A (1997) 1.34
Isolation of a NCK-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signaling. J Biol Chem (1996) 1.32
A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity (1999) 1.31